At the School of Health Innovation, participants gain knowledge, tools and networks that will enhance their ability to solve health challenges and develop the healthcare system.
Scientia Fellows Symposium, inspiring coffee meetings and important publications are some of the highlights of the programme from 2018.
Post.doc Asbjørn Christophersen has spear-headed the work that lead to identification of a narrow phenotype of gluten specific CD4+ T cells. This cell subset is also present in other autoimmune conditions and could be a target for future disease therapy.
Seed funding allocated to help encourage research collaborations across the wider NCMM network.
UiO:Life Science and vice-rector for research and innovation Per Morten Sandset invite all employees at UiO to breakfast meetings 27 May, 28 May, 29 May and 5 June at 8–9 AM.
Five EATRIS members, including NCMM and the Finnish Nordic EMBL partnership node, FIMM, assist reproducibility study
NCMM Associate Investigator, Professor Anne Simonesen, has been named as one of the winners of the King Olav V's Prize for Cancer Research 2019.
A drug development project started by the Taskén Group at NCMM is at the centre of a new and unique co-development agreement between a Norwegian start-up and an Indian pharmaceutical company.
The goal is to develop a digital lifestyle coach that can help you change unhealthy habits.
In a recent ambulance study, 1054 non-fatal opioid overdoses in central Oslo were examined to understand if opening hours at a safe injection facility affected these overdoses, and what role the overdose location may have on severity and ambulance transport.
Dr. Michael Hawrylycz from the Allen Institute gave a lecture on his research on brain atlases at the IMB Distinguished Seminar on October 5.
It was curiosity about the Human Brain Project that enticed the acclaimed researcher to come to Norway.
Sandra Lopez-Aviles and Anthony Mathelier both awarded grants as part of Norwegian Cancer Society’s annual open call.
SPARK Norway is UiO:Life Science’s innovation programme for health-related life sciences. Meet three of the SPARKees and get inspired to apply.
"Our product makes it easier to tailor IVF treatment to individual women," says Ana Lobato Pascual, who is starting a company with fellow students from the School of Health Innovation.
Six new teams have been admitted to UiO´s innovation programme SPARK Norway. They will develop their ideas within health-related life sciences for the benefit of patients and society.
What a year! These are the highlights of the programme from 2017.
The new innovation programme SPARK Norway at UiO has admitted the first research groups – so called SPARKees. They will develop their ideas within health-related life sciences further for the benefit of patients and society.
At the School of health innovation, participants will gain knowledge, tools and networks that will enhance their ability to solve future health challenges and further develop the healthcare system.
– The «moonshot» of my research is to find new therapeutic strategies to cure triple-negative breast cancer that is a challenging disease with the poorest prognosis of all breast cancer subtypes, Enrico Catalano says.
Research from the Morth Group shows that Zinc-binding plays an important role in the sensing and regulation of cellular pH in the human brain. Findings published in Nature Group's Scientific Reports
Jacques Dubochet, Joachim Frank and Richard Henderson awarded Nobel Prize in Chemistry 2017
The annual NLS Days conference took place on 12-14 September at the Malmö Convention Centre in Sweden.
UiO:Life Science plans the launch of the SPARK innovation programme, developed by Stanford University. The goal is to get more innovation out of basic research. The other two European SPARK programs visit Oslo this summer to share their experiences, and one of UiO's PhD students will test the program's summer school in Japan.
The board of UiO:Life Science has decided to support the newly established School of Health Innovation at UiO, NTNU and Karolinska Institutet. With this UiO:Life Science wants to contribute to establish a new strong player in the UiO ecosystem of innovation.
Study published in Cell Reports shows that the accessibility of DNA varies from patient to patient, and may act as a fingerprint for prostate cancer progression.